Seglitide (MK-678) is a potent, orally active somatostatin receptor 2 (SSTR2) agonist, and also a competitive antagonist of SSTR14, SSTR25, and SSTR28. Seglitide has antihypertensive effects and can inhibit plasma glucagon and growth hormone. Seglitide can be used for research on diabetes[1][2][3].
Molecular Weight:
808.96
Purity:
99.30
CAS Number:
[81377-02-8]
Formula:
C44H56N8O7
Target:
Somatostatin Receptor
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted